Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 0.6950
+0.0150 (2.21%)
Nov 3, 2026, 3:56 PM HKT
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 259.35 million as of November 3, 2026. It is the 33,140th most valuable company in the world and the 1,760th biggest in Hong Kong. Its market cap has decreased by 90.11% in one year.
Market Cap
259.35M
Enterprise Value
-146.67M
Revenue
383.95M
Global Rank
Country Rank
#1,760 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 259.35M, a decrease of -96.11%. That is a compound annual growth rate of -61.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 259.35M | -84.28% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wuhan YZY Biopharma | 775.40M |
| Brii Biosciences | 707.42M |
| Kintor Pharmaceutical | 666.64M |
| 3D Medicines | 641.85M |
| Sirnaomics | 449.75M |
| Uni-Bio Science Group | 394.10M |
| B&K Corporation | 384.74M |
| Transcenta Holding | 313.81M |